Golden State Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Golden State Wealth Management's PFE Position: Q2 2026 in Review
Golden State Wealth Management increased its Pfizer (PFE) stake by 11% in Q2 2026, buying an estimated $28.3K and bringing the position to 11,293 shares worth $272K. The position accounts for 0.02% of the portfolio, ranked #369.
Golden State Wealth Management first reported a position in PFE in Q1 2019 and has held it in 20 quarters since. The position peaked at $1.53M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Golden State Wealth Management held 11,293 shares of Pfizer worth $272K as of Q2 2026.
- Golden State Wealth Management bought 1,080 Pfizer shares in Q2 2026, an estimated $28.3K.
- Pfizer made up 0.02% of Golden State Wealth Management's portfolio in Q2 2026, its #369 holding.
- Golden State Wealth Management first reported a position in Pfizer in Q1 2019 and has held it in 20 quarters since.
- Golden State Wealth Management's Pfizer position peaked at $1.53M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.